ALLR
Closed
Allarity Therapeutics Inc
1.04
+0.03 (+2.97%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.01
Day's Range: 0.96 - 1.01
Send
sign up or login to leave a comment!
When Written:
1.68
Allarity Therapeutics Inc is a clinical-stage biotechnology company that focuses on developing and commercializing personalized medicine for cancer patients. The company's proprietary drug response predictor platform, called DRP, uses a patient's unique genetic profile to predict which cancer drugs will be most effective for that individual. Allarity Therapeutics aims to improve the success rate of cancer treatments and reduce the time and costs associated with drug development. The company's lead product candidate, dovitinib, is currently in clinical trials for the treatment of advanced liver cancer and advanced breast cancer. Allarity Therapeutics is headquartered in Denmark and has operations in the United States.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








